Lockdown effects on Parkinson's disease during COVID-19 pandemic: a pilot study.


Journal

Acta neurologica Belgica
ISSN: 2240-2993
Titre abrégé: Acta Neurol Belg
Pays: Italy
ID NLM: 0247035

Informations de publication

Date de publication:
Oct 2021
Historique:
received: 09 04 2021
accepted: 17 06 2021
pubmed: 3 7 2021
medline: 24 9 2021
entrez: 2 7 2021
Statut: ppublish

Résumé

The coronavirus-disease 2019 (COVID-19) outbreak precipitated prolonged lock-down measures. The subsequent social distancing, isolation, and reduction in mobility increased psychological stress, which may worsen Parkinson's disease (PD). Therefore, telemedicine has been proposed to provide care to PD patients. To evaluate the effects of lock-down on motor and nonmotor symptoms in PD patients during the COVID-19 pandemic and the feasibility of telemedicine. Motor and nonmotor aspects were longitudinally assessed using structured questionnaires at baseline (in-person, February 2020) and at follow-up (remote web-based video, lock-down) evaluation. Of the seventeen PD patients evaluated at baseline, fourteen agreed to participate in, and completed follow-up evaluations. There was an impairment of nonmotor aspects measured with the MDS-UPDRS part I (p < 0.001) during lock-down. Nine patients participated independently in the telemedicine evaluation while five needed help from relatives. Our preliminary findings suggest an impairment of nonmotor symptoms in PD patients and support the feasibility and need for telemedicine in monitoring PD patients during the COVID-19 pandemic, to guarantee optimal assistance with reducing the burden of infection. Our findings also suggest that movement disorder clinics should be carefully considering socio-demographics and clinical features when developing telemedicine programs.

Identifiants

pubmed: 34212285
doi: 10.1007/s13760-021-01732-z
pii: 10.1007/s13760-021-01732-z
pmc: PMC8248756
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1191-1198

Informations de copyright

© 2021. The Author(s).

Références

Mov Disord. 2010 Nov 15;25(15):2649-53
pubmed: 21069833
Mov Disord. 2008 Jan 30;23(2):183-9; quiz 313
pubmed: 17987654
Mov Disord. 2010 Aug 15;25(11):1652-9
pubmed: 20533449
Mov Disord. 2009 May 15;24(7):1073-6
pubmed: 19353687
Arch Neurol. 1989 Oct;46(10):1121-3
pubmed: 2803071
J Parkinsons Dis. 2020;10(4):1379-1382
pubmed: 32675421
J Parkinsons Dis. 2020;10(2):351-354
pubmed: 32250324
Lancet Neurol. 2009 May;8(5):464-74
pubmed: 19375664
J Neurol Sci. 2016 Aug 15;367:158-61
pubmed: 27423582
J Am Geriatr Soc. 2005 Apr;53(4):695-9
pubmed: 15817019
Mov Disord. 2020 Aug;35(8):1287-1292
pubmed: 32449528
Age Ageing. 1997 Sep;26(5):353-7
pubmed: 9351479
Mov Disord. 2020 May;35(5):711-715
pubmed: 32250460
Mov Disord. 2020 Jun;35(6):905-908
pubmed: 32347572
Qual Life Res. 1995 Jun;4(3):241-8
pubmed: 7613534
Neurology. 1967 May;17(5):427-42
pubmed: 6067254
J Neuropsychiatry Clin Neurosci. 1995 Winter;7(1):23-30
pubmed: 7711487
Mov Disord. 2020 Nov;35(11):1914-1915
pubmed: 32954522
J Parkinsons Dis. 2021;11(2):445-454
pubmed: 33749619
Mov Disord. 2020 Jul;35(7):1089-1093
pubmed: 32484584
J Health Soc Behav. 1983 Dec;24(4):385-96
pubmed: 6668417
Parkinsonism Relat Disord. 2013 Feb;19(2):218-21
pubmed: 23102808
J Gerontol A Biol Sci Med Sci. 1995 Jan;50A(1):M28-34
pubmed: 7814786
J Int Neuropsychol Soc. 2013 Mar;19(3):295-304
pubmed: 23351239
Int J Geriatr Psychiatry. 2018 Jan;33(1):151-158
pubmed: 28247480
Psychiatry Res. 1991 Aug;38(2):143-62
pubmed: 1754629
Mov Disord. 2008 Nov 15;23(15):2129-70
pubmed: 19025984
Mov Disord. 2015 Oct;30(12):1591-601
pubmed: 26474316
Funct Neurol. 2018 Jan/Mar;33(1):31-35
pubmed: 29633694
Age Ageing. 2005 Nov;34(6):614-9
pubmed: 16267188
Gait Posture. 2009 Nov;30(4):459-63
pubmed: 19660949
N Engl J Med. 2020 Apr 30;382(18):1679-1681
pubmed: 32160451
J Psychiatr Res. 1982-1983;17(1):37-49
pubmed: 7183759
Aging Ment Health. 2008 Sep;12(5):647-53
pubmed: 18855181
Mov Disord. 2020 Oct;35(10):1717-1718
pubmed: 32776602
BMJ. 2020 Apr 6;369:m1379
pubmed: 32253182
Parkinsonism Relat Disord. 2020 Sep;78:134-137
pubmed: 32827969
J Neural Transm (Vienna). 2017 Aug;124(8):901-905
pubmed: 28150045
Eur J Neurol. 2015 Sep;22(9):1280-7
pubmed: 26031920
Front Neurol. 2020 Oct 07;11:567413
pubmed: 33117262

Auteurs

Marika Falla (M)

Center for Mind/Brain Sciences-CIMeC, University of Trento, Rovereto, TN, Italy. marika.falla@unitn.it.
Institute of Mountain Emergency Medicine, Eurac Research, Bolzano, Italy. marika.falla@unitn.it.

Alessandra Dodich (A)

Center for Mind/Brain Sciences-CIMeC, University of Trento, Rovereto, TN, Italy.

Costanza Papagno (C)

Center for Mind/Brain Sciences-CIMeC, University of Trento, Rovereto, TN, Italy.
Psychology Department, Università degli studi di Milano-Bicocca, Milan, Italy.

Alessandro Gober (A)

Center for Mind/Brain Sciences-CIMeC, University of Trento, Rovereto, TN, Italy.

Pamela Narduzzi (P)

Center for Mind/Brain Sciences-CIMeC, University of Trento, Rovereto, TN, Italy.

Enrica Pierotti (E)

Center for Mind/Brain Sciences-CIMeC, University of Trento, Rovereto, TN, Italy.

Markus Falk (M)

Institute of Mountain Emergency Medicine, Eurac Research, Bolzano, Italy.

Francesca Zappini (F)

Center for Mind/Brain Sciences-CIMeC, University of Trento, Rovereto, TN, Italy.

Carlo Colosimo (C)

Department of Neurology, Santa Maria University Hospital, Terni, Italy.

Luca Turella (L)

Center for Mind/Brain Sciences-CIMeC, University of Trento, Rovereto, TN, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH